- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/20 - Nitrogen atoms
Patent holdings for IPC class C07D 237/20
Total number of patents in this class: 306
10-year publication summary
|
16
|
22
|
12
|
16
|
21
|
20
|
16
|
19
|
20
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10741 |
25 |
| BASF SE | 20945 |
9 |
| Bayer AG | 3330 |
9 |
| Janssen Pharmaceutica N.V. | 3377 |
8 |
| Bayer Pharma AG | 1052 |
7 |
| Northwestern University | 3401 |
7 |
| Xenon Pharmaceuticals Inc. | 190 |
7 |
| Arcus Biosciences, Inc. | 140 |
6 |
| Nihon Nohyaku Co., Ltd. | 327 |
6 |
| Corteva Agriscience LLC | 2686 |
6 |
| Bristol-myers Squibb Company | 4881 |
5 |
| Deutsches Krebsforschungszentrum | 418 |
5 |
| Oryzon Genomics S.A. | 106 |
5 |
| Board of Regents, The University of Texas System | 5821 |
4 |
| Mitsubishi Tanabe Pharma Corporation | 584 |
4 |
| PTC Therapeutics, Inc. | 485 |
4 |
| Skyhawk Therapeutics, Inc. | 111 |
4 |
| Raze Therapeutics, Inc. | 18 |
4 |
| Centre National de La Recherche Scientifique | 10465 |
3 |
| Sumitomo Chemical Company, Limited | 9047 |
3 |
| Other owners | 175 |